Eurofins stock: Eurofins reports 3.70 percent growth as its value reaches EUR 14.6 billion
Published on 10/23/2026 at 16:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRevenue growth and margin target
- Eurofins reported EUR 5.61 billion in nine-month revenue, up 3.70 percent on October 21, 2026.
- Organic growth accelerated from 2.50 percent in the first quarter to 3.50 percent in the third quarter of 2026.
- Eurofins stock costs EUR 84.29 at Lang & Schwarz on October 23, 2026 at 4:12 p.m. CEST, 0.15 percent below the 52-week high.
- Eurofins targets a 24.00 percent adjusted EBITDA margin for fiscal year 2027.
Eurofins reported EUR 5.61 billion in revenue for the first nine months of 2026, up 3.70 percent from the same period of 2025, while its stock reached a EUR 14.6 billion market value. The company published the update on October 21, 2026, according to Eurofins. At Lang & Schwarz, the stock was trading at EUR 84.29 on October 23, 2026 at 4:12 p.m. CEST.
Organic growth reached 3.50 percent
The operating trend improved through the year. Organic revenue growth rose from 2.50 percent in the first quarter to 3.00 percent in the second quarter and 3.50 percent in the third quarter of 2026, giving Eurofins a quantified sequential improvement of 1.00 percentage point.
For the full year, Eurofins said organic growth was likely to fall below its previous mid-single-digit objective. The company kept its profitability and cash-flow objectives unchanged, and expects acquisition revenue in 2026 to exceed its previous annualized objective of EUR 250.0 million.
What does the margin target mean?
Eurofins continues to target an adjusted EBITDA margin of 24.00 percent for fiscal year 2027, compared with 22.50 percent in fiscal year 2025. That represents a 1.50 percentage-point gap between the historical margin and the stated 2027 objective. The company also expects free cash flow to increase and cash conversion to remain strong.
Price position and investor dates
The EUR 84.29 Lang & Schwarz price was EUR 0.13 below the 52-week high of EUR 84.42 and EUR 29.43 above the 52-week low of EUR 54.86 on October 23, 2026. Market capitalization stood at EUR 14.6 billion, with a price-to-earnings ratio of 29.34 and volume of 111,958 shares at the latest quote.
Eurofins held an investor event in Amersfoort on October 23, 2026, and lists a further investor event in Toronto for November 11, 2026, according to Eurofins. The November date is the next scheduled corporate event identified in the investor calendar.
Revenue is rising while guidance softens
The latest numbers present a mixed operating picture. Revenue growth reached 3.70 percent and quarterly organic growth improved by 1.00 percentage point from the first to the third quarter, but the company now expects 2026 organic growth below its earlier mid-single-digit objective. The unchanged margin and cash-flow goals put execution of the laboratory network and acquisition program at the center of the investment case.
Eurofins stock was trading at EUR 84.29 at Lang & Schwarz on October 23, 2026 at 4:12 p.m. CEST, 0.15 percent below the 52-week high of EUR 84.42. The further course of trading is shown by the continuously updated real-time quote of Eurofins stock.
Eurofins stock facts
- Company: Eurofins Scientific SE
- ISIN: FR0014000MR3
- Ticker: ERF
- Primary exchange: Euronext Paris
- Price Lang & Schwarz (as of October 23, 2026, 4:12 p.m. CEST): EUR 84.29
- Market capitalization: EUR 14.6 billion (as of October 23, 2026)
- 52-week range: EUR 54.86-EUR 84.42 (as of October 23, 2026)
- Sector / Industry: Healthcare / Medical Diagnostics and Research
Market context: Market report CAC 40.
